 | Up a level |
Glatzer, Markus; Horber, D.; Montemurro, M.; Winterhalder, R.; Inauen, R.; Berger, M. D.; Pestalozzi, B.; Pederiva, S.; Pless, M.; Putora, P. M. (2020). Choice of first line systemic treatment in pancreatic cancer among national experts. Pancreatology, 20(4), pp. 686-690. Elsevier 10.1016/j.pan.2020.03.012
Helbling, D.; Bodoky, G.; Gautschi, O.; Sun, H.; Bosman, F.; Gloor, Beat; Burkhard, R.; Winterhalder, R.; Madlung, Axel; Rauch, Daniel; Saletti, P.; Widmer, L.; Borner, M.; Baertschi, D.; Yan, P.; Benhattar, J.; Leibundgut, Elisabeth O.; Bougel, S.; Koeberle, D. (2013). Neoadjuvant chemoradiotherapy with or without panitumumab in patients with wild-type KRAS, locally advanced rectal cancer (LARC): a randomized, multicenter, phase II trial SAKK 41/07. Annals of oncology, 24(3), pp. 718-725. Oxford University Press 10.1093/annonc/mds519
